HIRATA Kenichi

J-GLOBAL         Last updated: Jun 26, 2018 at 03:09
 
Avatar
Name
HIRATA Kenichi
Affiliation
Kobe University
Section
Graduate School of Medicine Faculty of Medical Sciences
Job title
Professor

Research Areas

 
 

Awards & Honors

 
Apr 2004
血管内皮由来リパーゼ(EDL)の脂質代謝と動脈硬化、血管障害に形成過程にはたす役割の解明, Takeda medical research Foundation, 財団法人 代謝異常治療研究基金
 
Oct 2003
血管内皮由来リパーゼ(EDL)の脂質代謝と動脈硬化形成過程にはたす役割の解明, Suzuken Memrial Foundation, 医科学応用研究財団
Winner: IRATA Kenichi
 

Published Papers

 
Commensal bacteria at the crossroad between cholesterol homeostasis and chronic inflammation in atherosclerosis
KasaharaK, TanoueT, Yamashita Tomoya, YodoiK, MatsumotoT, EmotoT, MizoguchiT, HayashiT, KitanoN, Sasaki Naoto, AtarashiK, HondaK, Hirata Ken-ichi
J Lipid Res   58(3) 519-528   Mar 2017   [Refereed]
Predictors and Clinical Outcomes of Transient Responders to Cardiac Resynchronization Therapy
IchiboriH, Fukuzawa Koji, KiuchiK, MatsumotoA, KonishiH, ImadaH, HyogoK, KuroseJ, TatsumiK, Tanaka Hidekazu, Hirata Ken-ichi
Pacing Clin Electrophysiol   40(3) 301-309   Mar 2017   [Refereed]
Right ventricular relative wall thickness as a predictor of outcomes and of right ventricular reverse remodeling for patients with pulmonary hypertension
SanoH, Tanaka Hidekazu, MotojiY, FukudaY, MochizukiY, HataniY, MatsuzoeH, HatazawaK, ShimouraH, OokaJ, Ryo-KoriyamaK, NakayamaK, Matsumoto Kensuke, EmotoN, Hirata Ken-ichi
Int J Cardiovasc Imaging   33(3) 313-321   Mar 2017   [Refereed]
The differences between bisecting and off-center cuts of the aortic root: The three-dimensional anatomy of the aortic root reconstructed from the living heart
Mori Shunpei, AndersonRH, TaharaN, IzawaY, TobaT, FujiwaraS, ShimoyamaS, WatanabeY, Nishii Tatsuya, KonoAK, Takahashi Satoru, Hirata Ken-ichi
Echocardiography   34(3) 453-461   Mar 2017   [Refereed]
Diversity and Determinants of the Three-dimensional Anatomical Axis of the Heart as Revealed Using Multidetector-row Computed Tomography
Mori Shunpei, AndersonRH, TaharaN, IzawaY, TobaT, FujiwaraS, ShimoyamaS, WatanabeY, Nishii Tatsuya, KonoAK, Hirata Ken-ichi
Anat Rec (Hoboken)      Feb 2017   [Refereed]

Misc

 
Gut Microbiota and Coronary Artery Disease
Yamashita Tomoya, EmotoT, Sasaki Naoto, Hirata Ken-ichi
Int Heart J   57(6) 663-671   Dec 2016   [Refereed]
【虚血性心疾患UPDATE】 冠動脈疾患基礎研究の進歩 腸管免疫、腸内細菌と冠動脈硬化
山下智也, Hirata Ken-ichi
医学のあゆみ   259(6号) 597-603   Nov 2016   [Invited]
腸内細菌と諸疾患-ここまで明らかになった腸内細菌と全身疾患の関連】 循環器疾患と腸内細菌
江本拓央, Yamashita Tomoya, Hirata Ken-ichi
カレントテラピー   34(11) 1089-1094   Nov 2016
Very early stage left ventricular endocardial dysfunction of patients with hypereosinophilic syndrome
YamamotoT, Tanaka Hidekazu, KurimotoC, ImanishiT, HayashiN, Saegusa Jun, Morinobu Akio, Hirata Ken-ichi, KawanoS
Int J Cardiovasc Imaging   32(9) 1357-1361   Sep 2016   [Refereed]
【腸内細菌学の新潮流-基礎医学的見地から新規治療開発まで-】 腸内細菌と循環器疾患
Yamashita Tomoya, Hirata Ken-ichi
最新医学   71(9) 1795-1801   Sep 2016   [Invited]

Books etc

 
心不全診療Q&A エキスパート106人からの回答 / II.心不全診療Q&A 5.慢性心不全の薬物療法 (8)β遮断薬を入れるタイミングはどのように考えたらよいですか? (9)β遮断薬を増量する目安には何を用いればよいでしょうか? (10)β遮断薬はどれくらいまで増量すべきでしょうか?
Kobayashi Seimi, Hirata Kenichi
中外医学社   Sep 2012   
「冠動脈疾患の病態に迫る」 新・心臓病診療プラクティスシリーズ12 / I.冠動脈プラークの病態に迫る 2.成因に迫る 4)高LDLコレステロール血症/低HDLコレステロール血症の関与.
Hirata Kenichi (Part:Joint Work)
文光堂   Dec 2008   

Conference Activities & Talks

 
Alterations of gut microbiota composition and microbiota-associated metabolites in chronic heart failure [Invited]
林 友鴻, Yamashita Tomoya, 吉田 尚史, 田畑 論子, 江本 拓央, 佐々木 直人, 溝口 泰司, Hilman Zulkifli Amin, Irino Yasuhiro, Toh Ryuji, Shinohara Masakazu, Hirata Ken-ichi
The 82th Annual Scientific Meeting of the Japanese Circulation Society   Mar 2018   The Japanese Circulation Society
We investigate the relationship between the gut microbiota and heart failure.
Association of Body Fat Mass with Left Ventricular Myocardial Systolic Longitudinal Dysfunction in Type 2 Diabetes Mellitus [Invited]
羽渓優, Tanaka Hidekazu, 望月泰秀, 須藤麻貴子, 柴田奈緒, 横田駿, 向井淳, 久松恵理子, 高田裕基, 曽我文隆, 堂國久美子, 畑澤圭子, 松添弘樹, Matsumoto Kensuke, Hirata Ken-ichi
The 82nd Annual Scientific Meeting of the Japanese Circulation Society   Mar 2018   The Japanese Circulation Society
Background: Left ventricular (LV) longitudinal myocardial systolic dysfunction (LVSD) has been identified in type 2 diabetes mellitus (T2DM) patients, and it should be considered the first marker of a preclinical form of DM-related cardiac dysfunc...
Echocardiography, Atrial Fibrillation [Invited]
Fumitaka Soga, Tanaka Hidekazu, Yasuhide Mochizuki, Jun Mukai, Makiko Suto, Hiroki Takada, Kumiko Dokuni, Yutaka Hatani, Hiroki Matsuzoe, Keiko Hatazawa, Junichi Ooka, Hiroyuki Sano, Eriko Hisamatsu, Matsumoto Kensuke, Hirata Ken-ichi
The 82nd Annual Scientific Meeting of the Japanese Circulation Society   Mar 2018   The Japanese Circulation Society
Background: Atrial fibrillation (AF) causes structural and electrical remodeling. Left atrial (LA) volume is a robust predictor for recurrence of AF after pulmonary vein isolation, however, recurrence of AF can be associated with multiple factors....
Gut microbiota and their relevant metabolites could be novel biomarkers and innovative therapeutic targets of chronic heart failure [Invited]
林 友鴻, Yamashita Tomoya, Hirata Ken-ichi
The 82th Annual Scientific Meeting of the Japanese Circulation Society   Mar 2018   The Japanese Circulation Society
We investigate the relationship between the gut microbiota and heart failure.
Identification of Determinants of Cholesterol Uptake Capacity, a Novel Indicator for HDL Functionality [Invited]
Toshihiko Oshita, Toh Ryuji, Mitsumasa Okano, Shigeyasu Tsuda, Ko-ichi Watanabe, Kobayashi Seimi, Hara Tetsuya, Shinohara Masakazu, Irino Yasuhiro, Katsuhiro Murakami, Amane Harada, Ishida Tatsuro, Hirata Ken-ichi
The 82th Annual Scientific Meeting of the Japanese Circulation Society   Mar 2018   Japanese Circulation Society
Background: Recently, we established a simple, high-throughput, cell-free assay system to evaluate the capacity of high-density lipoprotein (HDL) to accept additional cholesterol, named cholesterol uptake capacity (CUC), and demonstrated its feasi...